Optomed Oyj (HLSE: OPTOMED)
Health Care · Health Care Equipment & Supplies · FI
€1.68
-0.94% today · -55.7% 1Y
Optomed Oyj (HLSE: OPTOMED) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $42.43M and employs 110 people.
Over the last twelve months the share price has lost 55.7%, trading between 1.33 and 4.33.
Tweenvest scores Optomed Oyj across four factors: quality 52/100, value 53/100, growth 52/100. Its strongest factor is value.
OPTOMED price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.43M
- Revenue (TTM)
- $18.39M
- P/E
- —
- EPS
- -0.27
- Dividend yield
- —
- Beta (5Y)
- 1.57
- 52-week high
- €4.33
- 52-week low
- €1.33
- Avg volume (3M)
- —
- Shares outstanding
- 21.43M
- Employees
- 110
- Next earnings
- —
About Optomed Oyj
Optomed Oyj, established in 2004 and headquartered in Oulu, Finland, is a medical technology company specializing in the development, production, and sale of portable devices for retinal examination and advanced screening software. The company operates globally, with a presence in Finland and China, structured into dedicated Devices and Software segments. Its Device division focuses on fundus cameras, serving a broad spectrum of medical specialists, including ophthalmologists, pediatricians, endocrinologists, neurologists, and general practitioners. These camera products are marketed under Optomed's own brand names such as Optomed Smartscope Pro, Aurora, Polaris, and Halo, and are also provided as OEM products under labels including Pictor Plus, Pictor Prestige, Visuscout 100, Fundus Module 300, and Signal. The Software segment offers a comprehensive suite of solutions. For eye health, this includes Avenue Eye Screen for managing the workflow of eye disease screening and monitoring (like diabetic retinopathy), Avenue Archive for healthcare data storage and transmission, Avenue Telemedicine for remote image analysis, Avenue AI for automated diabetic retinopathy screening, and Avenue Sync for seamless integration of fundus cameras with hospital systems. Beyond eye care, Optomed provides Avenue Cancer Screen for managing breast, cervical, and colorectal cancer screenings; Optomed RIS for optimizing diagnostic processes in healthcare imaging units; Sectra PACS, a scalable system for high-volume healthcare providers; Optomed Service Portal for supporting imaging service operations; Facad for visible light imaging and cephalometric tracing; and Sectra PACS Pathology, a digital solution for the distribution and diagnosis of scanned glass slides. Furthermore, Optomed extends professional IT consulting services to government bodies. The company's products and solutions are distributed through OEMs, authorized distributors, and its direct sales channels. Its primary clientele includes hospitals, specialized eye clinics, and both independent and chain optician stores.
- ISIN
- FI4000410881
- Founded
- 2004
- Listed since
- Dec 5, 2019
- Exchange
- OMX Nordic Exchange Helsinki
- Currency
- EUR
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $197.44B | $114.10 | -1.75% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $130.86B | $370.42 | -0.38% |
| Stryker CorporationNYSE: SYK | $126.45B | $329.67 | -0.28% |
| Medtronic plcNYSE: MDT | $117.78B | $92.02 | +0.97% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.25B | €159.20 | +0.03% |
| Boston Scientific CorporationNYSE: BSX | $69.81B | $48.17 | -3.39% |
| HOYA CorporationTSE: 7741 | $52.40B | ¥24,965.00 | -0.12% |
| Edwards Lifesciences CorporationNYSE: EW | $52.33B | $90.78 | -0.10% |
Figures last refreshed Aug 18, 2026.